US2015291931A1PendingUtilityA1
Mesendoderm and mesoderm cell populations
Assignee: ICAHN SCHOOL MED MOUNT SINAIPriority: May 17, 2002Filed: Jun 26, 2015Published: Oct 15, 2015
Est. expiryMay 17, 2022(expired)· nominal 20-yr term from priority
A61P 9/04A61P 43/00A61P 35/02A61P 9/00A61P 7/06A61P 3/10A61P 19/00A61P 21/04A61P 1/16A61P 17/00C12N 5/0606C12N 2501/415G01N 33/5073C12N 2500/90C12N 5/0603C12N 2506/02C12N 2501/16
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides cell populations that are enriched for mesendoderm and mesoderm, and cell populations that are enriched for endoderm. In accordance with the present invention, a selectable marker gene has been recombinantly targeted to the brachyury locus to allow the isolation and characterization of cell populations that comprise brachyury positive mesendoderm and mesoderm cells. The cell populations of the invention are useful for generating cells for cell replacement therapy.
Claims
exact text as granted — not AI-modified1 .- 30 . (canceled)
31 . An isolated mammalian cell population enriched for brachyury + and KDR/Flk-1 + precardiac mesoderm cells derived from brachyury + and KDR/Flk-1 − cells wherein the KDR/Flk-1 + cells are capable of becoming cells of a cardiomyocyte lineage.
32 . An isolated mammalian cell population enriched for brachyury + and KDR/Flk-1 − pre-hemangioblast mesoderm cells wherein the cells are capable of becoming cells of a vascular smooth muscle lineage, an endothelial cell lineage, and a hematopoietic cell lineage, and are not capable of becoming cells of endodermal or ectodermal lineages.Join the waitlist — get patent alerts
Track US2015291931A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.